NCT03936374View on ClinicalTrials.gov

A Study to Evaluate the Effect of Omeprazole on the Pharmacokinetics of BMS-986205 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

May 8, 2019

Primary Completion Date

July 20, 2019

Study Completion Date

July 20, 2019

Conditions
Healthy
Interventions
DRUG

BMS-986205

Participants will receive BMS-986205 on Days 1 and 15

DRUG

omeprazole

Participants will receive omeprazole on Days 10 to 15

Trial Locations (1)

78744

PPD Phase I Clinic, Austin

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT03936374 - A Study to Evaluate the Effect of Omeprazole on the Pharmacokinetics of BMS-986205 in Healthy Participants | Biotech Hunter | Biotech Hunter